-
1
-
-
0026572734
-
Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis
-
Craven PA, DeRubertis FR. Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis. Carcinogenesis 1992;13:541-6.
-
(1992)
Carcinogenesis
, vol.13
, pp. 541-546
-
-
Craven, P.A.1
DeRubertis, F.R.2
-
2
-
-
0028452329
-
Aspirin reduces the incidence of colonic carcinoma in the dimethylhydrazine rat animal model
-
Davis AE, Patterson F. Aspirin reduces the incidence of colonic carcinoma in the dimethylhydrazine rat animal model. Aust N Z J Med 1994;24:301-3.
-
(1994)
Aust N Z J Med
, vol.24
, pp. 301-303
-
-
Davis, A.E.1
Patterson, F.2
-
3
-
-
0028107160
-
Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1,2-dimethylhydrazine
-
Mereto E, Frencia L, Ghia M. Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1,2-dimethylhydrazine. Cancer Lett 1994;76:5-9.
-
(1994)
Cancer Lett
, vol.76
, pp. 5-9
-
-
Mereto, E.1
Frencia, L.2
Ghia, M.3
-
4
-
-
0024211723
-
A protective effect of sulindac against chemically-induced primary colonic tumours in mice
-
Moorghen M, Ince P, Finney KJ, Sunter JP, Appleton DR, Watson AJ. A protective effect of sulindac against chemically-induced primary colonic tumours in mice. J Pathol 1988; 156:341-7.
-
(1988)
J Pathol
, vol.156
, pp. 341-347
-
-
Moorghen, M.1
Ince, P.2
Finney, K.J.3
Sunter, J.P.4
Appleton, D.R.5
Watson, A.J.6
-
5
-
-
0019428705
-
Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment
-
Narisawa T, Sato M, Tani M, Kudo T, Takahashi T, Goto A. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res 1981;41: 1954-7.
-
(1981)
Cancer Res
, vol.41
, pp. 1954-1957
-
-
Narisawa, T.1
Sato, M.2
Tani, M.3
Kudo, T.4
Takahashi, T.5
Goto, A.6
-
6
-
-
0021229118
-
Reduction of carcinogenicity of N-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E2 (PGE2) against indomethacin
-
Narisawa T, Hermanek P, Habs M, Schmahl D. Reduction of carcinogenicity of N-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E2 (PGE2) against indomethacin. J Cancer Res Clin Oncol 1984;108:239-42.
-
(1984)
J Cancer Res Clin Oncol
, vol.108
, pp. 239-242
-
-
Narisawa, T.1
Hermanek, P.2
Habs, M.3
Schmahl, D.4
-
7
-
-
0019792996
-
Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine
-
Pollard M, Luckert PH. Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science 1981;214:558-9.
-
(1981)
Science
, vol.214
, pp. 558-559
-
-
Pollard, M.1
Luckert, P.H.2
-
8
-
-
0021051198
-
The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat
-
Pollard M, Luckert PH, Schmidt MA. The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat. Cancer Lett 1983; 21:57-61.
-
(1983)
Cancer Lett
, vol.21
, pp. 57-61
-
-
Pollard, M.1
Luckert, P.H.2
Schmidt, M.A.3
-
9
-
-
0024331456
-
Prevention and treatment of primary intestinal tumors in rats by piroxicam
-
Pollard M, Luckert PH. Prevention and treatment of primary intestinal tumors in rats by piroxicam. Cancer Res 1989;49:6471-3.
-
(1989)
Cancer Res
, vol.49
, pp. 6471-6473
-
-
Pollard, M.1
Luckert, P.H.2
-
10
-
-
0023270948
-
Dose- Related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development
-
Reddy BS, Maruyama H, Kelloff G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Cancer Res 1987;47: 5340-6.
-
(1987)
Cancer Res
, vol.47
, pp. 5340-5346
-
-
Reddy, B.S.1
Maruyama, H.2
Kelloff, G.3
-
11
-
-
0027183769
-
Inhibitory effect of aspirin on azoxymethane- Induced colon carcinogenesis in F344 rats
-
Reddy BS, Ruo CV, Rivenson A, Kelloff G. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 1993;14:1493-7.
-
(1993)
Carcinogenesis
, vol.14
, pp. 1493-1497
-
-
Reddy, B.S.1
Ruo, C.V.2
Rivenson, A.3
Kelloff, G.4
-
14
-
-
85036493916
-
Aspirin and aspirin-like drugs alter the growth rate and cell cycle distribution of HT29 colon cancer cells
-
Shiff SJ, Qiao L, Tsai LL, Arvind P, Rigas B. Aspirin and aspirin-like drugs alter the growth rate and cell cycle distribution of HT29 colon cancer cells [abstract]. Proc Am Assoc Cancer Res 1994;35:A3765.
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
-
-
Shiff, S.J.1
Qiao, L.2
Tsai, L.L.3
Arvind, P.4
Rigas, B.5
-
15
-
-
0023100898
-
Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues
-
Bennett A, Civier A, Hensby CN, Melhuish PB, Stamford IF. Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. Gut 1987;28:315-8.
-
(1987)
Gut
, vol.28
, pp. 315-318
-
-
Bennett, A.1
Civier, A.2
Hensby, C.N.3
Melhuish, P.B.4
Stamford, I.F.5
-
16
-
-
0027371123
-
Altered eicosanoid levels in human colon cancer
-
Rigas B, Goldman IS, Levine L. Altered eicosanoid levels in human colon cancer. J Lab Clin Med 1993;122:518-23.
-
(1993)
J Lab Clin Med
, vol.122
, pp. 518-523
-
-
Rigas, B.1
Goldman, I.S.2
Levine, L.3
-
17
-
-
0018110856
-
Excess risk of lymphomas, leukemia, and myeloma in patient with rheumatoid arthritis
-
Isomaki HA, Hakulinen T, Joutsenlahti V. Excess risk of lymphomas, leukemia, and myeloma in patient with rheumatoid arthritis. J Chronic Dis 1978;31:691-6.
-
(1978)
J Chronic Dis
, vol.31
, pp. 691-696
-
-
Isomaki, H.A.1
Hakulinen, T.2
Joutsenlahti, V.3
-
18
-
-
0026417761
-
A hypothesis: Nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer
-
Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 1991;83:355-8.
-
(1991)
J Natl Cancer Inst
, vol.83
, pp. 355-358
-
-
Rosenberg, L.1
Palmer, J.R.2
Zauber, A.G.3
Warshauer, M.E.4
Stolley, P.D.5
Shapiro, S.6
-
19
-
-
0023687241
-
Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne Colorectal Cancer Study
-
Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res 1988;48:4399-404.
-
(1988)
Cancer Res
, vol.48
, pp. 4399-4404
-
-
Kune, G.A.1
Kune, S.2
Watson, L.F.3
-
21
-
-
0027512524
-
Aspirin use and risk of fatal cancer
-
Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr. Aspirin use and risk of fatal cancer. Cancer Res 1993;53:1322-7.
-
(1993)
Cancer Res
, vol.53
, pp. 1322-1327
-
-
Thun, M.J.1
Namboodiri, M.M.2
Calle, E.E.3
Flanders, W.D.4
Heath Jr., C.W.5
-
22
-
-
0027237664
-
Effect of aspirin and non-steroidal anti- Inflammatory drugs on colorectal adenomas: Case-control study of subjects participating in the Nottingham faecal occult blood screening programme
-
Logan RF, Little J, Hawtin PG, Hardcastle JD. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. BMJ 1993;307:285-9.
-
(1993)
BMJ
, vol.307
, pp. 285-289
-
-
Logan, R.F.1
Little, J.2
Hawtin, P.G.3
Hardcastle, J.D.4
-
23
-
-
0027245529
-
Reduced risk of large- Bowel adenomas among aspirin users
-
The Polyp Prevention Study Group
-
Greenberg ER, Baron JA, Freeman DH Jr, Mandel JS, Haile R. Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. J Natl Cancer Inst 1993;85:912-6.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 912-916
-
-
Greenberg, E.R.1
Baron, J.A.2
Freeman Jr., D.H.3
Mandel, J.S.4
Haile, R.5
-
24
-
-
0027528555
-
Incidence of cancer among patients with rheumatoid arthritis
-
Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993;85:307-11.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 307-311
-
-
Gridley, G.1
McLaughlin, J.K.2
Ekbom, A.3
Klareskog, L.4
Adami, H.O.5
Hacker, D.G.6
-
25
-
-
0028085411
-
Nonsteroidal anti-inflammatory drugs and colorectal cancer
-
Muscat JE, Stellman SD, Wynder EL. Nonsteroidal anti-inflammatory drugs and colorectal cancer. Cancer 1994;74:1847-54.
-
(1994)
Cancer
, vol.74
, pp. 1847-1854
-
-
Muscat, J.E.1
Stellman, S.D.2
Wynder, E.L.3
-
26
-
-
0028344925
-
Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer
-
Peleg II, Maibach HT, Brown SH, Wilcox CM. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med 1994;154:394-9.
-
(1994)
Arch Intern Med
, vol.154
, pp. 394-399
-
-
Peleg, I.I.1
Maibach, H.T.2
Brown, S.H.3
Wilcox, C.M.4
-
27
-
-
0028556801
-
Aspirin use and the risk for colorectal cancer and adenoma in male health professionals
-
Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994;121:241-6.
-
(1994)
Ann Intern Med
, vol.121
, pp. 241-246
-
-
Giovannucci, E.1
Rimm, E.B.2
Stampfer, M.J.3
Colditz, G.A.4
Ascherio, A.5
Willett, W.C.6
-
28
-
-
0028843830
-
Aspirin and other nonsteroidal anti- inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals
-
Martinez ME, McPherson RS, Levin B, Annegers JF. Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals. Cancer Epidemiol Biomarkers Prev 1995;4:703-7.
-
(1995)
Cancer Epidemiol Biomarkers Prev
, vol.4
, pp. 703-707
-
-
Martinez, M.E.1
McPherson, R.S.2
Levin, B.3
Annegers, J.F.4
-
29
-
-
0024418625
-
Aspirin use and chronic disease: A cohort study of the elderly
-
Paganini-Hill A, Chao A, Ross RK, Henderson BE. Aspirin use and chronic disease: a cohort study of the elderly. BMJ 1989;299: 1247-50.
-
(1989)
BMJ
, vol.299
, pp. 1247-1250
-
-
Paganini-Hill, A.1
Chao, A.2
Ross, R.K.3
Henderson, B.E.4
-
30
-
-
0027161914
-
Low-dose aspirin and incidence of colorectal tumors in a randomized trial
-
Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 1993;85:1220-4.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 1220-1224
-
-
Gann, P.H.1
Manson, J.E.2
Glynn, R.J.3
Buring, J.E.4
Hennekens, C.H.5
-
31
-
-
0017102984
-
Subversive activity of syngeneic tumor cells as an escape mechanism from immune surveillance and the role of prostaglandins
-
Plescia OJ, Grinwich K, Plescia AM. Subversive activity of syngeneic tumor cells as an escape mechanism from immune surveillance and the role of prostaglandins. Ann N Y Acad Sci 1976;276:455-65.
-
(1976)
Ann N Y Acad Sci
, vol.276
, pp. 455-465
-
-
Plescia, O.J.1
Grinwich, K.2
Plescia, A.M.3
-
32
-
-
0018080422
-
Mechanism of inhibition of tumour growth by aspirin and indomethacin
-
Lynch NR, Castes M, Astoin M, Salomon JC. Mechanism of inhibition of tumour growth by aspirin and indomethacin. Br J Cancer 1978; 38:503-12.
-
(1978)
Br J Cancer
, vol.38
, pp. 503-512
-
-
Lynch, N.R.1
Castes, M.2
Astoin, M.3
Salomon, J.C.4
-
33
-
-
0022972247
-
Profiles of eicosanoid production by superficial and proliferative colonic epithelial cells and sub-epithelial colonic tissue
-
Craven PA, DeRubertis FR. Profiles of eicosanoid production by superficial and proliferative colonic epithelial cells and sub-epithelial colonic tissue. Prostaglandins 1986;32:387-99.
-
(1986)
Prostaglandins
, vol.32
, pp. 387-399
-
-
Craven, P.A.1
DeRubertis, F.R.2
-
34
-
-
0023948928
-
Role of enhanced arachidonate availability through phospholipase A2 pathway in mediation of increased prostaglandin synthesis by glomeruli from diabetic rats
-
Craven PA, Patterson MC, DeRubertis FR. Role of enhanced arachidonate availability through phospholipase A2 pathway in mediation of increased prostaglandin synthesis by glomeruli from diabetic rats. Diabetes 1988;37: 429-35.
-
(1988)
Diabetes
, vol.37
, pp. 429-435
-
-
Craven, P.A.1
Patterson, M.C.2
DeRubertis, F.R.3
-
35
-
-
0023848405
-
Sustained increase in the proliferation of rat colonic mucosa during chronic treatment with aspirin
-
Craven PA, Thornburg K, DeRubertis FR. Sustained increase in the proliferation of rat colonic mucosa during chronic treatment with aspirin. Gastroenterology 1988;94:567-75.
-
(1988)
Gastroenterology
, vol.94
, pp. 567-575
-
-
Craven, P.A.1
Thornburg, K.2
DeRubertis, F.R.3
-
36
-
-
0019119725
-
Early alterations in rat colonic mucosal cyclic nucleotide metabolism and protein kinase activity induced by 1,2-dimethylhydrazine
-
DeRubertis FR, Craven PA. Early alterations in rat colonic mucosal cyclic nucleotide metabolism and protein kinase activity induced by 1,2-dimethylhydrazine. Cancer Res 1980;40: 4589-98.
-
(1980)
Cancer Res
, vol.40
, pp. 4589-4598
-
-
DeRubertis, F.R.1
Craven, P.A.2
-
37
-
-
0020524631
-
Role of local prostaglandin synthesis in the modulation of proliferative activity of rat colonic epithelium
-
Craven PA, Saito R, DeRubertis FR. Role of local prostaglandin synthesis in the modulation of proliferative activity of rat colonic epithelium. J Clin Invest 1983;72:1365-75.
-
(1983)
J Clin Invest
, vol.72
, pp. 1365-1375
-
-
Craven, P.A.1
Saito, R.2
DeRubertis, F.R.3
-
38
-
-
0006581419
-
Arachidonic acid cascade inhibitors in chemoprevention of human colonic cancer: Preliminary studies
-
Wattenberg L, Lipkin M, Boone C, Kelloff G, editors. Boca Raton (FL): CRC Press
-
Earnest D, Hixson L, Finely PR, Blackwell G, Einspahr J, Emerson S, et al. Arachidonic acid cascade inhibitors in chemoprevention of human colonic cancer: preliminary studies. In: Wattenberg L, Lipkin M, Boone C, Kelloff G, editors. Cancer chemoprevention. Boca Raton (FL): CRC Press, 1992:165-80.
-
(1992)
Cancer Chemoprevention
, pp. 165-180
-
-
Earnest, D.1
Hixson, L.2
Finely, P.R.3
Blackwell, G.4
Einspahr, J.5
Emerson, S.6
-
39
-
-
0025053902
-
Relationship between blood plasma prostaglandin E2 and liver and lung metastases in colorectal cancer
-
Narisawa T, Kusaka H, Yamazaki Y, Takahashi M, Koyama H, Koyama K, et al. Relationship between blood plasma prostaglandin E2 and liver and lung metastases in colorectal cancer. Dis Colon Rectum 1990;33: 840-5.
-
(1990)
Dis Colon Rectum
, vol.33
, pp. 840-845
-
-
Narisawa, T.1
Kusaka, H.2
Yamazaki, Y.3
Takahashi, M.4
Koyama, H.5
Koyama, K.6
-
40
-
-
0028803728
-
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
-
Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493-501.
-
(1995)
Cell
, vol.83
, pp. 493-501
-
-
Tsujii, M.1
DuBois, R.N.2
-
41
-
-
9344257283
-
Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis
-
Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 1996;56:2556-60.
-
(1996)
Cancer Res
, vol.56
, pp. 2556-2560
-
-
Boolbol, S.K.1
Dannenberg, A.J.2
Chadburn, A.3
Martucci, C.4
Guo, X.J.5
Ramonetti, J.T.6
-
42
-
-
0030606299
-
Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
-
Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87:803-9.
-
(1996)
Cell
, vol.87
, pp. 803-809
-
-
Oshima, M.1
Dinchuk, J.E.2
Kargman, S.L.3
Oshima, H.4
Hancock, B.5
Kwong, E.6
-
43
-
-
0024325516
-
Tolerability of the synthetic retinoid Fenretinide (HPR)
-
Costa A, Malone W, Perloff M, Buranelli F, Campa T, Dossena G, et al. Tolerability of the synthetic retinoid Fenretinide (HPR). Eur J Cancer Clin Oncol 1989;25:805-8.
-
(1989)
Eur J Cancer Clin Oncol
, vol.25
, pp. 805-808
-
-
Costa, A.1
Malone, W.2
Perloff, M.3
Buranelli, F.4
Campa, T.5
Dossena, G.6
-
44
-
-
0021286467
-
Minimization of salicylic acid formation during preparation of aspirin products for analysis by high- Performance liquid chromatography
-
Bevitt RN, Mather JR, Sharman DC. Minimization of salicylic acid formation during preparation of aspirin products for analysis by high-performance liquid chromatography. Analyst 1984;109:1327-9.
-
(1984)
Analyst
, vol.109
, pp. 1327-1329
-
-
Bevitt, R.N.1
Mather, J.R.2
Sharman, D.C.3
-
45
-
-
0020040544
-
Improved liquid-chromatography of aspirin, salicylate, and salicyluric acid in plasma, with a modification for determining aspirin metabolites in urine
-
Buskin JN, Upton RA, Williams RL. Improved liquid-chromatography of aspirin, salicylate, and salicyluric acid in plasma, with a modification for determining aspirin metabolites in urine. Clin Chem 1982;28:1200-3.
-
(1982)
Clin Chem
, vol.28
, pp. 1200-1203
-
-
Buskin, J.N.1
Upton, R.A.2
Williams, R.L.3
-
46
-
-
0030136577
-
Adherence to single daily dose of aspirin in a chemoprevention trial. An evaluation of self-report and microelectronic monitoring
-
Burney KD, Krishnan K, Ruffin MT, Zhang D, Brenner DE. Adherence to single daily dose of aspirin in a chemoprevention trial. An evaluation of self-report and microelectronic monitoring. Arch Fam Med 1996;5:297-300.
-
(1996)
Arch Fam Med
, vol.5
, pp. 297-300
-
-
Burney, K.D.1
Krishnan, K.2
Ruffin, M.T.3
Zhang, D.4
Brenner, D.E.5
-
48
-
-
0015025451
-
A test for differences between treatment means when several dose levels are compared with a zero dose control
-
Williams DA. A test for differences between treatment means when several dose levels are compared with a zero dose control. Biometrics 1971;27:103-17.
-
(1971)
Biometrics
, vol.27
, pp. 103-117
-
-
Williams, D.A.1
-
49
-
-
0015357959
-
The comparison of several dose levels with a zero dose control
-
Williams DA. The comparison of several dose levels with a zero dose control. Biometrics 1972;28:519-31.
-
(1972)
Biometrics
, vol.28
, pp. 519-531
-
-
Williams, D.A.1
-
50
-
-
0344865487
-
Aspirin: Pharmacokinetics and pharmacodynamic effects on platelets and vascular function
-
Vane J, Botting R, editors. New York: Chapman & Hall Medical
-
Charman W, Kerins D, Fitzgerald G. Aspirin: pharmacokinetics and pharmacodynamic effects on platelets and vascular function. In: Vane J, Botting R, editors. Aspirin and other salicylates. New York: Chapman & Hall Medical, 1992:74-106.
-
(1992)
Aspirin and Other Salicylates
, pp. 74-106
-
-
Charman, W.1
Kerins, D.2
Fitzgerald, G.3
-
51
-
-
10544256606
-
Urinary salicylate excretion in subjects eating a variety of diets shows that amounts of bioavailable salicylates in food are low
-
Janssen PL, Hollman PC, Reichman E, Venema DP, van Staveren WA, Katan MB. Urinary salicylate excretion in subjects eating a variety of diets shows that amounts of bioavailable salicylates in food are low. Am J Clin Nutr 1996;64:743-7.
-
(1996)
Am J Clin Nutr
, vol.64
, pp. 743-747
-
-
Janssen, P.L.1
Hollman, P.C.2
Reichman, E.3
Venema, D.P.4
Van Staveren, W.A.5
Katan, M.B.6
-
53
-
-
0025845649
-
Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial
-
Ridker PM, Manson JE, Gaziano JM, Buring JE, Hennekens CH. Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial. Ann Intern Med 1991;114:835-9.
-
(1991)
Ann Intern Med
, vol.114
, pp. 835-839
-
-
Ridker, P.M.1
Manson, J.E.2
Gaziano, J.M.3
Buring, J.E.4
Hennekens, C.H.5
-
54
-
-
0025326479
-
Effects of early intervention with low-dose aspirin (100 mg) on infarct size, reinfarction and mortality in anterior wall acute myocardial infarction
-
Verheugt FW, van der Laarse A, Funke-Kupper AJ, Sterkman LG, Galema TW, Roos JP. Effects of early intervention with low-dose aspirin (100 mg) on infarct size, reinfarction and mortality in anterior wall acute myocardial infarction. Am J Cardiol 1990;66: 267-70.
-
(1990)
Am J Cardiol
, vol.66
, pp. 267-270
-
-
Verheugt, F.W.1
Van Der Laarse, A.2
Funke-Kupper, A.J.3
Sterkman, L.G.4
Galema, T.W.5
Roos, J.P.6
-
55
-
-
0025666949
-
Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians
-
Manson JE, Grobbee DE, Stampfer MJ, Taylor JO, Goldhaber SZ, Gaziano JM, et al. Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. Am J Med 1990;89:772-6.
-
(1990)
Am J Med
, vol.89
, pp. 772-776
-
-
Manson, J.E.1
De Grobbee2
Stampfer, M.J.3
Taylor, J.O.4
Goldhaber, S.Z.5
Gaziano, J.M.6
-
56
-
-
0024205547
-
Superior prevention of reinfarction by 30 mg/d aspirin compared with 1000 mg/d: Results of a two years follow- Up study in Cottbus
-
Forster W, Hoffmann W. Superior prevention of reinfarction by 30 mg/d aspirin compared with 1000 mg/d: results of a two years follow-up study in Cottbus. Biomed Biochim Acta 1988;47:S248-51.
-
(1988)
Biomed Biochim Acta
, vol.47
-
-
Forster, W.1
Hoffmann, W.2
-
57
-
-
0029664607
-
G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2
-
DuBois RN, Shao J, Tsujii M, Sheng H, Beauchamp RD. G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res 1996;56:733-7.
-
(1996)
Cancer Res
, vol.56
, pp. 733-737
-
-
DuBois, R.N.1
Shao, J.2
Tsujii, M.3
Sheng, H.4
Beauchamp, R.D.5
-
58
-
-
0025234545
-
Biomarkers as intermediate end point in chemoprevention trials
-
Lippman SM, Lee JS, Lotan R, Hittelman W, Wargovich MJ, Hong W. Biomarkers as intermediate end point in chemoprevention trials. J Natl Cancer Inst 1990;82:555-60.
-
(1990)
J Natl Cancer Inst
, vol.82
, pp. 555-560
-
-
Lippman, S.M.1
Lee, J.S.2
Lotan, R.3
Hittelman, W.4
Wargovich, M.J.5
Hong, W.6
-
59
-
-
0028985728
-
Measurement of prostaglandin E2 in rectal mucosa in human subjects: A method study
-
Finley PR, Bogert CL, Alberts DS, Einspahr J, Earnest DL, Blackwell G, et al. Measurement of prostaglandin E2 in rectal mucosa in human subjects: a method study. Cancer Epidemiol Biomarkers Prev 1995;4:239-44.
-
(1995)
Cancer Epidemiol Biomarkers Prev
, vol.4
, pp. 239-244
-
-
Finley, P.R.1
Bogert, C.L.2
Alberts, D.S.3
Einspahr, J.4
Earnest, D.L.5
Blackwell, G.6
-
60
-
-
0028685471
-
Clinical development plan: Aspirin
-
Kelloff GJ, Crowell JA, Boone CW, Steele VE, Lubet RA, Greenwald P, et al. Clinical development plan: aspirin. J Cell Biochem Suppl 1994;20:74-85.
-
(1994)
J Cell Biochem Suppl
, vol.20
, pp. 74-85
-
-
Kelloff, G.J.1
Crowell, J.A.2
Boone, C.W.3
Steele, V.E.4
Lubet, R.A.5
Greenwald, P.6
|